FDA Releases Draft Guidance for Combined Oral Contraceptives Labeling

Summary

The Food and Drug Administration (FDA) has released a draft guidance for the combined oral contraceptives industry, aiming to standardize labeling for healthcare providers and patients. The guidance, set to be finalized, will help physicians and patients better understand the efficacy and safety risks of these products.